The University of Rochester Medical Center is taking part in a clinical trial for using the drug remdesivir as a potential coronavirus treatment. Preliminary results are ‘promising’ in using remdesivir to treat adults diagnosed with COVID-19.
The Medical Center is one of only nine Vaccine Treatment and Evaluation Unit (VTEU) sites in the US conducting this type of research.
While the trial is still ongoing, this early Rochester data is a positive sign.